3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
3
Not yet recruiting
2
Enrolling by invitation
2
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Neoplasms
31
Prostatic Neoplasms
13
Breast Neoplasms
13
Colorectal Neoplasms
12
Hematologic Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lung Neoplasms
6
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Uterine Cervical Neoplasms
4
Pancreatic Neoplasms
4
Myasthenia Gravis
4
Melanoma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myeloid, Acute
4
Head and Neck Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Adenocarcinoma
4
Pain
3
Ovarian Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Hematopoietic and Lymphatic System Neoplasm
3
Hematologic Diseases
3
Glioma
3
Gastrointestinal Neoplasms
3
Carcinoma, Renal Cell
3
Brain Neoplasms
3
Anxiety Disorders
3
Urinary Bladder Neoplasms
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Hypoxia
×
90 days
×
Clear all
NCT07617038
2026-06-01
HERO
Université de Montréal
Phase NA
Enrolling by invitation
60 enrolled
NCT07494006
2026-03-27
OLV
Peking University People's Hospital
Enrolling by invitation
44 enrolled